Skip to search.
 TSX Up 0.47% TSX Ventures Up 1.46%

Athersys, Inc. (ATHX)

-NasdaqCM
2.31 Up 0.06(2.67%) Apr 29, 4:00PM EDT
Prev Close:2.25
Open:2.26
Bid:2.25 x 100
Ask:2.58 x 200
1y Target Est:5.00
Beta:-0.941494
Next Earnings Date: 5-May-16ATHX Earnings announcement
Day's Range:2.25 - 2.35
52wk Range:0.94 - 2.90
Volume:369,687
Avg Vol (3m):1,075,200
Market Cap:193.39M
P/E (ttm):N/A
EPS (ttm):-0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ATHXUp 2.67%193.39M
OSIRDown 4.43%193.28M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):118.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.39
Quarterly EPS Est (Mar-16) :-0.08
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.21

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. The company’s lead platform product, MultiStem cell therapy, an allogeneic stem cell product, which is in Phase... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback